These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 27838786)

  • 21. Phenethyl isothiocyanate induces DNA damage-associated G2/M arrest and subsequent apoptosis in oral cancer cells with varying p53 mutations.
    Yeh YT; Yeh H; Su SH; Lin JS; Lee KJ; Shyu HW; Chen ZF; Huang SY; Su SJ
    Free Radic Biol Med; 2014 Sep; 74():1-13. PubMed ID: 24952138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sodium Fluoride Arrests Renal G2/M Phase Cell-Cycle Progression by Activating ATM-Chk2-P53/Cdc25C Signaling Pathway in Mice.
    Luo Q; Guo H; Kuang P; Cui H; Deng H; Liu H; Lu Y; Wei Q; Chen L; Fang J; Zuo Z; Deng J; Li Y; Wang X; Zhao L
    Cell Physiol Biochem; 2018; 51(5):2421-2433. PubMed ID: 30537743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gypenosides Synergistically Enhances the Anti-Tumor Effect of 5-Fluorouracil on Colorectal Cancer In Vitro and In Vivo: A Role for Oxidative Stress-Mediated DNA Damage and p53 Activation.
    Kong L; Wang X; Zhang K; Yuan W; Yang Q; Fan J; Wang P; Liu Q
    PLoS One; 2015; 10(9):e0137888. PubMed ID: 26368019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer.
    DiTullio RA; Mochan TA; Venere M; Bartkova J; Sehested M; Bartek J; Halazonetis TD
    Nat Cell Biol; 2002 Dec; 4(12):998-1002. PubMed ID: 12447382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. XRRA1 Targets ATM/CHK1/2-Mediated DNA Repair in Colorectal Cancer.
    Wang W; Guo M; Xia X; Zhang C; Zeng Y; Wu S
    Biomed Res Int; 2017; 2017():5718968. PubMed ID: 29082250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resveratrol analogue (E)-8-acetoxy-2-[2-(3,4-diacetoxyphenyl)ethenyl]-quinazoline induces G₂/M cell cycle arrest through the activation of ATM/ATR in human cervical carcinoma HeLa cells.
    Kim JY; Choi HE; Lee HH; Shin JS; Shin DH; Choi JH; Lee YS; Lee KT
    Oncol Rep; 2015 May; 33(5):2639-47. PubMed ID: 25812484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneous nuclear ribonucleoprotein L facilitates recruitment of 53BP1 and BRCA1 at the DNA break sites induced by oxaliplatin in colorectal cancer.
    Hu W; Lei L; Xie X; Huang L; Cui Q; Dang T; Liu GL; Li Y; Sun X; Zhou Z
    Cell Death Dis; 2019 Jul; 10(8):550. PubMed ID: 31320608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological significance of ATM-Chk2 expression in sporadic breast cancers: a comprehensive analysis in large cohorts.
    Abdel-Fatah TM; Arora A; Alsubhi N; Agarwal D; Moseley PM; Perry C; Doherty R; Chan SY; Green AR; Rakha E; Ball G; Ellis IO; Madhusudan S
    Neoplasia; 2014 Nov; 16(11):982-91. PubMed ID: 25425972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Knockdown of DNA-PKcs inhibits cell cycle and its mechanism of drug-resistant Bel7402/5-Fu hepatocellular carcinoma cells].
    Li D; Liu Y; Yu C; Liu X; Fan F
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Dec; 33(12):1647-1651. PubMed ID: 29382425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. XRCC2-Deficient Cells are Highly Sensitive to 5-Fluorouracil in Colorectal Cancer.
    Zhang YZ; An JH; Liu YX; Wu XC; Han SS; Ren XQ; Qin CJ
    Cell Physiol Biochem; 2017; 43(3):1207-1219. PubMed ID: 28977800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.
    Li T; Gao F; Zhang XP
    Oncol Rep; 2015 Feb; 33(2):607-14. PubMed ID: 25482885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Novel Inhibitor Targets Both Wnt Signaling and ATM/p53 in Colorectal Cancer.
    Cheng J; Dwyer M; Okolotowicz KJ; Mercola M; Cashman JR
    Cancer Res; 2018 Sep; 78(17):5072-5083. PubMed ID: 30032112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer.
    Zhang Y; Talmon G; Wang J
    Cell Death Dis; 2015 Aug; 6(8):e1845. PubMed ID: 26247730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-375-3p enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.
    Xu F; Ye ML; Zhang YP; Li WJ; Li MT; Wang HZ; Qiu X; Xu Y; Yin JW; Hu Q; Wei WH; Chang Y; Liu L; Zhao Q
    Cancer Sci; 2020 May; 111(5):1528-1541. PubMed ID: 32073706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ATM may be a protective factor in endometrial carcinogenesis with the progesterone pathway.
    Shan W; Wang C; Zhang Z; Luo X; Ning C; Yu Y; Feng Y; Gu C; Chen X
    Tumour Biol; 2015 Mar; 36(3):1529-37. PubMed ID: 25608836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53/microRNA-374b/AKT1 regulates colorectal cancer cell apoptosis in response to DNA damage.
    Gong H; Cao Y; Han G; Zhang Y; You Q; Wang Y; Pan Y
    Int J Oncol; 2017 May; 50(5):1785-1791. PubMed ID: 28339062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance.
    de la Cruz-Morcillo MA; Valero ML; Callejas-Valera JL; Arias-González L; Melgar-Rojas P; Galán-Moya EM; García-Gil E; García-Cano J; Sánchez-Prieto R
    Oncogene; 2012 Mar; 31(9):1073-85. PubMed ID: 21841826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of p53 codon 72 polymorphism and inactive p53 mutation predicts chemosensitivity to 5-fluorouracil in colorectal cancer.
    Tominaga T; Iwahashi M; Takifuji K; Hotta T; Yokoyama S; Matsuda K; Higashiguchi T; Oku Y; Nasu T; Yamaue H
    Int J Cancer; 2010 Apr; 126(7):1691-701. PubMed ID: 19810096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scutellaria barbata D. Don inhibits 5-fluorouracil resistance in colorectal cancer by regulating PI3K/AKT pathway.
    Lin J; Feng J; Yang H; Yan Z; Li Q; Wei L; Lai Z; Jin Y; Peng J
    Oncol Rep; 2017 Oct; 38(4):2293-2300. PubMed ID: 28849113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic Implications of p53 Status on Cancer Cell Fate Following Exposure to Ionizing Radiation and the DNA-PK Inhibitor M3814.
    Sun Q; Guo Y; Liu X; Czauderna F; Carr MI; Zenke FT; Blaukat A; Vassilev LT
    Mol Cancer Res; 2019 Dec; 17(12):2457-2468. PubMed ID: 31551253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.